Brazil ANVISA public meeting on drug serialization, tracking system set
Thursday, January 09, 2014
Brazil's ANVISA, the Brazilian Health Surveillance Agency, has published the first public hearing to discuss the creation and implementation of the National Drug Control System to use for meeting the new resolution mandating pharmaceutical serialization and drug tracking to be phased between 2015 to 2016.
The meeting is set for January 23, 2014 from 9am to 12pm at ANVISA headquarters in Brasilia, Brazil. Here is a link to more information.
The National System of Drug Control framework published on December 10th, 2013 provides for unit-level serialization and supply chain-wide drug tracking from manufacture to dispensation where each node in the supply chain maintains their own database of drug product and downstream transaction tracking data.
Our recent webinar on the regulation detailed specifics on the new regulation from serialization requirements to drug tracking capabilities that companies need to implement by December 10, 2015.
- New Drug Counterfeiting Bill Introduced in US Congress
- FDA to Exercise Enforcement Discretion for the Drug Supply Chain Security Act
- FDA Publishes DSCSA Reporting Requirements for Wholesalers and 3PLs
- FDA Releases DSCSA Data Exchange Guidance
- Korea Sets New Pharmaceutical Serialization Deadlines
- HDMA ASN Guidelines for DSCSA Implementation Updated
- India Defers Primary-Level Drug Serialization
- FDA Releases DSCSA Suspect Product Guidance
- FDA Releases DSCSA Data Exchange Public Workshop Readout
- Presentations now available for FDA Workshop on DSCSA